Key statistics
On Monday, Xoma Royalty Corp (0M26:LSE) closed at 25.53, 35.94% above the 52 week low of 18.78 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 25.53 |
| Low | 25.53 |
| Bid | -- |
| Offer | -- |
| Previous close | 27.00 |
| Average volume | 24.00 |
|---|---|
| Shares outstanding | 12.38m |
| Free float | 12.17m |
| P/E (TTM) | 34.21 |
| Market cap | 316.14m USD |
| EPS (TTM) | 0.7462 USD |
Data delayed at least 20 minutes, as of Mar 02 2026 14:30 GMT.
More ▼
Announcements
- XOMA Royalty to Present at Investor Conferences in March
- XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
- XOMA Royalty Announces CFO Transition
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
- XOMA Royalty Declares Quarterly Preferred Stock Dividends
- XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
- XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
- XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
- XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
More ▼
